Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. - Bouchet,C.; Spyratos,F.; Martin,P.M.; HacPne,K.; Gentile,A.; Oglobine,J. (Br J Cancer, 1994)